Companies /Healthcare
Teladoc Health Inc
NYSE: TDOC Health Information Services
$8.66
▲ $0.15 (+1.70%) today
Markets open · 4:11pm ET

Teladoc Health (TDOC) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
86%
EPS beat rate
+9.72%
Avg. EPS surprise
Consecutive EPS beats
TDOC vs Market · 30-day return after each reportTDOCS&P 500
0%+20%+1.0%+6.7%Q1 25+4.5%+1.7%Q2 25−14.2%+0.3%Q3 25−3.9%−8.3%Q4 25+24.4%+5.7%Q1 26−3.7%+3.4%Q2 26
0%+20%Q1 25Q3 25Q1 26
TDOC EPS Trend · estimate vs actualEstimateActual
$-0.60$-0.40$-0.20$0.00$-0.36$-0.53Q1 25$-0.31$-0.19Q2 25$-0.31$-0.28Q3 25$-0.22$-0.14Q4 25$-0.39$-0.36Q1 26$-0.23$-0.21Q2 26$-0.19$-0.15Q3 26
$-0.60$-0.40$-0.20$0.00Q1 25Q3 25Q1 26Q3 26
TDOC Revenue Trend · estimate vs actualEstimateActual
$0$200.0M$400.0M$600.0M$619.2M$629.4MQ1 25$622.8M$631.9MQ2 25$626.1M$626.4MQ3 25$635.3M$642.3MQ4 25$611.4M$613.8MQ1 26$616.3M$606.9MQ2 26$590.5M$605.1MQ3 26
$0$200.0M$400.0M$600.0MQ1 25Q3 25Q1 26Q3 26

How Often Does Teladoc Health Beat Earnings Estimates?

Teladoc Health beat EPS estimates in 6 of its last 7 reported quarters, and has beaten 6 quarters in a row.

TDOC quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 Includes amortization of intangibles of $88.3 million ($0.49 per share pre-tax), stock-based compensation of $11.6 million ($0.06 per share pre-tax), and restructuring costs of $4.4 million ($0.02 per share pre-tax) $-0.15 est. $-0.19 +19.66% $605.1M est. $590.5M +2.48%
Q2 2026 $-0.21 est. $-0.23 +6.67% $606.9M est. $616.3M −1.53%
Q1 2026 GAAP net loss includes amortization of intangibles of $89.8 million ($0.50 per share pre-tax), stock-based compensation of $14.6 million ($0.08 per share pre-tax) and restructuring costs of $12.0 million ($0.07 per share pre-tax), primarily severance $-0.36 est. $-0.39 +6.90% $613.8M est. $611.4M +0.41%
Q4 2025 $-0.14 est. $-0.22 +35.19% $642.3M est. $635.3M +1.09%
Q3 2025 $-0.28 est. $-0.31 +8.94% $626.4M est. $626.1M +0.06%
Q2 2025 $-0.19 est. $-0.31 +38.71% $631.9M est. $622.8M +1.46%
Q1 2025 $-0.53 est. $-0.36 −48.04% $629.4M est. $619.2M +1.64%

Figures from SEC filings and company reports. Not investment advice.